Extracorporeal Membrane Oxygenation Market to Witness Continued Growth by 2033 - Allied Market Research

The global Extracorporeal Membrane Oxygenation Market has witnessed significant growth in recent years, driven by the increasing prevalence of respiratory and cardiac diseases, along with advancements in ECMO technology. According to Allied Market Research, the Extracorporeal Membrane Oxygenation Market was valued at $527.5 million in 2023 and is projected to reach $952.2 million by 2035, growing at a CAGR of 5% from 2024 to 2035.

Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/A08108

Extracorporeal Membrane Oxygenation Market Dynamics
Several factors contribute to the robust expansion of the Extracorporeal Membrane Oxygenation Market:
• Rising Prevalence of Respiratory Disorders: Conditions such as asthma and chronic obstructive pulmonary disease (COPD) have become more common. For instance, the Centers for Disease Control and Prevention (CDC) reports that approximately 25 million people in the U.S. have asthma. This increasing prevalence significantly drives the demand for ECMO products.
• Technological Advancements: Continuous innovations in ECMO systems have enhanced their efficiency and safety, making them more accessible and reliable for critical care.(Wikipedia)
• Aging Population: The global increase in the elderly population, who are more susceptible to severe cardiac and respiratory conditions, has led to a higher demand for advanced life-support technologies like ECMO.

Extracorporeal Membrane Oxygenation Market Segmentation
The Extracorporeal Membrane Oxygenation Market is segmented based on components, modulation, application, patient type, and region.
• By Component:
◦ Oxygenator: Dominated the market in 2023 and is expected to register the highest CAGR during the forecast period.
◦ Pumps
◦ Controllers
◦ Cannula
◦ Accessories

• By Modulation:
◦ Veno-Arterial (VA): Dominated the market share in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
◦ Veno-Venous (VV)
◦ Others

• By Application:
◦ Respiratory Disorders: Led the market in terms of revenue in 2023 and is expected to register the highest CAGR during the forecast period.
◦ Cardiac Diseases
◦ Extracorporeal Cardiopulmonary Resuscitation (ECPR)

• By Patient Type:
◦ Adult: Dominated the market in terms of revenue in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
◦ Pediatric
◦ Neonates

Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/purchase-enquiry/A08108

Regional Insights
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
• North America: Held the largest market share in 2023, attributed to its robust healthcare infrastructure, high adoption of advanced technologies, and favorable reimbursement policies.
• Asia-Pacific: Expected to grow at the highest CAGR during the forecast period, driven by improving healthcare infrastructure, increasing investments in advanced medical technologies, and a rising prevalence of cardiovascular and respiratory conditions.

Key Players in the Extracorporeal Membrane Oxygenation Market
Several prominent companies operate in the Extracorporeal Membrane Oxygenation Market, including:
• Abbott Laboratories
• Medtronic plc
• Getinge AB
• LivaNova PLC
• Terumo Corporation
• MicroPort Scientific Corporation
• Nipro Medical Corporation
• Fresenius Medical Care
• Sorin Group
• MAQUET Holding

These companies have adopted strategies such as product approvals, partnerships, expansions, and collaborations to enhance their market presence. For instance, in April 2023, Abbott announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company's life support system.

The Extracorporeal Membrane Oxygenation Market is poised for substantial growth in the coming years. Factors such as the increasing prevalence of respiratory and cardiac diseases, technological advancements, and the growing geriatric population are expected to drive market expansion. Additionally, emerging economies are likely to offer lucrative opportunities due to improving healthcare infrastructure and rising awareness about advanced life-support technologies.

In conclusion, the Extracorporeal Membrane Oxygenation Market is experiencing significant growth, driven by various factors including the rising prevalence of respiratory and cardiac conditions, technological innovations, and demographic changes. With continuous advancements and strategic initiatives by key players, the market is expected to witness sustained expansion in the foreseeable future.

Read Full Market Synopsis: https://www.alliedmarketresearch.com/extracorporeal-membrane-oxygenation-market-A08108

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.